Correlation Between Briacell Therapeutics and Equillium

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Briacell Therapeutics and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Briacell Therapeutics and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Briacell Therapeutics Corp and Equillium, you can compare the effects of market volatilities on Briacell Therapeutics and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Briacell Therapeutics with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Briacell Therapeutics and Equillium.

Diversification Opportunities for Briacell Therapeutics and Equillium

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Briacell and Equillium is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Briacell Therapeutics Corp and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Briacell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Briacell Therapeutics Corp are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Briacell Therapeutics i.e., Briacell Therapeutics and Equillium go up and down completely randomly.

Pair Corralation between Briacell Therapeutics and Equillium

Given the investment horizon of 90 days Briacell Therapeutics Corp is expected to generate 3.08 times more return on investment than Equillium. However, Briacell Therapeutics is 3.08 times more volatile than Equillium. It trades about 0.07 of its potential returns per unit of risk. Equillium is currently generating about -0.16 per unit of risk. If you would invest  65.00  in Briacell Therapeutics Corp on September 13, 2024 and sell it today you would lose (0.14) from holding Briacell Therapeutics Corp or give up 0.22% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Briacell Therapeutics Corp  vs.  Equillium

 Performance 
       Timeline  
Briacell Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Briacell Therapeutics Corp are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Briacell Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Equillium 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Equillium is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Briacell Therapeutics and Equillium Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Briacell Therapeutics and Equillium

The main advantage of trading using opposite Briacell Therapeutics and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Briacell Therapeutics position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.
The idea behind Briacell Therapeutics Corp and Equillium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments